Firategrast (SB 683699) is an orally active and specific alpha4beta1/alpha4beta7 integrin antagonist that reduces the transport of lymphocytes into the central nervous system (CNS) and decreases multiple sclerosis (MS) activity. It is used in relapsing-remitting multiple sclerosis, associated with modest reductions in CD4, CD8, and CD19 lymphocyte counts in cerebrospinal fluid.
Molecular Weight:
499.5
Purity:
99.16%
CAS Number:
[402567-16-2]
Formula:
C27H27F2NO6
Target:
Integrin
TQ0291
* VAT and and shipping costs not included. Errors and price changes excepted